GLIOSEQ Trademark

Trademark Overview

On Monday, January 19, 2015, a trademark application was filed for GLIOSEQ with the United States Patent and Trademark Office. The USPTO has given the GLIOSEQ trademark a serial number of 86507095. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Sunday, October 2, 2022. This trademark is owned by UPMC. The GLIOSEQ trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

medical testing services, namely, next generation sequencing test for diagnosis, prognosis, and treatment of brain tumors
glioseq

General Information

Serial Number86507095
Word MarkGLIOSEQ
Filing DateMonday, January 19, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSunday, October 2, 2022
Registration Number4952469
Registration DateTuesday, May 3, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2015

Trademark Statements

Pseudo MarkGLIO SEQ
Goods and Servicesmedical testing services, namely, next generation sequencing test for diagnosis, prognosis, and treatment of brain tumors

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 30, 2015
Primary Code044
First Use Anywhere DateFriday, May 1, 2015
First Use In Commerce DateFriday, May 1, 2015

Trademark Owner History

Party NameUPMC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15219
Party NameUPMC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15219
Party NameUPMC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15219

Trademark Events

Event DateEvent Description
Sunday, October 2, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, October 2, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, October 2, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 5, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, May 3, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 3, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 29, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, March 26, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 18, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 12, 2016USE AMENDMENT FILED
Wednesday, February 17, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 12, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, July 21, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 26, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 18, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 18, 2015ASSIGNED TO LIE
Thursday, March 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 26, 2015ASSIGNED TO EXAMINER
Saturday, January 31, 2015NOTICE OF PSEUDO MARK E-MAILED
Friday, January 30, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 22, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

glioseq prognosis diagnosis treatment brain tumors test sequencing services testing namely